Literature DB >> 1629347

Outer membrane protein subtypes of Haemophilus influenzae type b isolates causing invasive disease in Victoria, Australia, from 1988 to 1990.

D A Clements1, S J MacInnes, G L Gilbert.   

Abstract

Outer membrane protein subtyping of 187 isolates of Haemophilus influenzae type b (Hib), isolated from children with invasive Hib disease in Victoria, Australia, showed that a single outer membrane protein subtype (1VA) was responsible for 83% of the infections. It was identical to that responsible for the majority of cases of invasive Hib disease in Europe.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1629347      PMCID： PMC265399          DOI： 10.1128/jcm.30.7.1879-1881.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  12 in total

Review 1.  Epidemiology of Haemophilus influenzae type b infections in the United States.

Authors:  C V Broome
Journal:  Pediatr Infect Dis J       Date:  1987-08       Impact factor: 2.129

2.  Characteristics of major outer membrane proteins of Haemophilus influenzae.

Authors:  L van Alphen; T Riemens; J Poolman; H C Zanen
Journal:  J Bacteriol       Date:  1983-08       Impact factor: 3.490

3.  Outer membrane protein subtypes and biotypes of Haemophilus influenzae type b: relation between strains isolated in 1934-1954 and 1977-1980.

Authors:  S J Barenkamp; D M Granoff; M Pittman
Journal:  J Infect Dis       Date:  1983-12       Impact factor: 5.226

4.  A taxonomic study of the genus Haemophilus, with the proposal of a new species.

Authors:  M Kilian
Journal:  J Gen Microbiol       Date:  1976-03

5.  Homogeneity of cell envelope protein subtypes, lipopolysaccharide serotypes, and biotypes among Haemophilus influenzae type b from patients with meningitis in The Netherlands.

Authors:  L van Alphen; T Riemens; J Poolman; C Hopman; H C Zanen
Journal:  J Infect Dis       Date:  1983-07       Impact factor: 5.226

6.  Haemophilus influenzae type b infections in Victoria, Australia, 1985 to 1987.

Authors:  G L Gilbert; D A Clements; S J Broughton
Journal:  Pediatr Infect Dis J       Date:  1990-04       Impact factor: 2.129

7.  Haemophilus influenzae type b strains of outer membrane subtypes 1 and 1c cause different types of invasive disease.

Authors:  A K Takala; L van Alphen; J Eskola; J Palmgren; P Bol; P H Mäkelä
Journal:  Lancet       Date:  1987-09-19       Impact factor: 79.321

8.  Comparison of outer membrane protein subtypes of Haemophilus influenzae type b isolates from healthy children in the general population and from diseased patients.

Authors:  C M Hampton; S J Barenkamp; D M Granoff
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

9.  A population genetic framework for the study of invasive diseases caused by serotype b strains of Haemophilus influenzae.

Authors:  J M Musser; D M Granoff; P E Pattison; R K Selander
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

Review 10.  Epidemiology of invasive Haemophilus influenzae type b disease among children in Finland before vaccination with Haemophilus influenzae type b conjugate vaccine.

Authors:  A K Takala; J Eskola; H Peltola; P H Mäkelä
Journal:  Pediatr Infect Dis J       Date:  1989-05       Impact factor: 2.129
View more
  3 in total

1.  Sporadic invasion of cultured epithelial cells by Haemophilus influenzae type b.

Authors:  P D Johnson; F Oppedisano; V Bennett-Wood; G L Gilbert; R M Robins-Browne
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

2.  Differing antibody responses to Haemophilus influenzae type b after meningitis or epiglottitis.

Authors:  P D Johnson; M Hanlon; D Isaacs; G L Gilbert
Journal:  Epidemiol Infect       Date:  1996-02       Impact factor: 2.451

3.  Antibodies to Haemophilus influenzae type b outer membrane proteins in children with epiglottitis or meningitis and in healthy controls.

Authors:  P D Johnson; S J MacInnes; G L Gilbert
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.